Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
- |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Kura Oncology, Inc.
Kura Oncology, Inc. is a biopharmaceutical company focused on developing innovative cancer therapies. The company is engaged in the discovery and development of precision medicines for the treatment of various types of cancers. Kura Oncology's goal is to address the unmet medical needs of cancer patients by targeting specific genetic alterations in their tumors. The company's pipeline includes potential therapies for solid tumors and hematologic malignancies. Kura Oncology aims to improve patient outcomes and provide more effective treatment options through targeted therapies.
|